www.abbi.org.br
Other organizations in the same industry
Overcoming cancer through earlier detection
Media additives to enhance cell culture systems I IP sold to C-LEcta in Sep 2025.
Creating class-leading ADCs with enhanced tumor specificity
Mapping the immune interactome to discover novel immunotherapies
This company is also known as